Outcome of Annual General Meeting held on September 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chandra Bhagat Pharma held its 22nd AGM on September 30, 2025, from 4:00 PM to 5:00 PM at its registered office in Matunga, Mumbai, with 8 members present. The meeting was chaired by Managing Director Mr. Hemant C Bhagat. Two ordinary resolutions were passed by show of hands with 100% votes in favour: (1) adoption of audited financial statements for FY ended March 31, 2025, and (2) re-appointment of Mr. Hemant C Bhagat as a Director liable to retire by rotation. Total votes polled were 52,81,056 shares, representing 69.99% of the 75,45,056 outstanding shares, with no votes cast against either resolution. Promoter group polled 96.91% of their holdings, while public non-institutional shareholders had very low participation at just 0.16%.
This is a routine AGM outcome filing — all resolutions passed with overwhelming support and no dissent, indicating smooth governance. The re-appointment of the existing Managing Director maintains continuity in leadership. Low public participation in voting is notable but not unusual for a closely-held company.